Arbutus Biopharma Corp (ABUS)

Investing Cash Flow

-$1.66M

Quarterly · Period ending: · USD

ABUS logo

ABUS Investing Cash Flow

Latest reported-$1.66M
ABUS Quarterly Cash from Investing (-$252.25K → -$1.66M)
High-resolution chart · PNG

ABUS investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-1,661,000
2,199,000
-1,361,000
-10,019,000
15,611,000
11,349,000
13,411,000
-11,986,000
9,829,000
11,694,000
22,225,000
10,429,000
1,441,000
16,678,000
12,682,000
-13,738,000
-13,830,000
-60,056,000
-8,121,000
15,969,000
-38,747,000
18,221,000
-49,976,000
14,097,000
23,371,000
-2,401,000
-58,822,000
16,155,000
9,972,000
61,033,000
44,784,000
24,378,000
14,980,000
-75,666,000
709,000
5,305,000
-1,390,000
23,195,000
731,000
-880,000
-85,393,000
-13,582,000
-1,804,000
-17,733,000
-10,327,000
37,546,000
1,058,000
-443,000
-43,238,000
-335,000
-194,898
-119,395
-206,472
-202,997
-1,955
2,528
-11,727
-841
-4,050
3,886
-1,428
-56,855
-33,661
-89,567
-165,533
-542,054
12,011,553
178,324
-12,245,023
3,904,823
-876,200
2,135,034
2,449,446
-462,934
-241,716
-252,247
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.